Search results
Start date:
Jun 10, 2020
End date:
Jun 12, 2020
Transcatheter Interventions Online
Don't miss this innovative educational event focused on novel interventional practice lead by Prof Nicolas Van Mieghem (Erasmus MC, Rotterdam, NL). Entirely digital over 3 days (see Full Agenda), and free to HCPs, it will include updated education and live cases for cardiologists, interventionalists and surgeons interested in transcatheter…
View more
Author(s):
David L Joyce
Added:
1 year ago
Bionert Stent Angiographic Study
Author(s):
Eulogio García Fernandez
,
Didier Carrie
,
Amadeu Betriu
,
et al
Added:
3 years ago
Article
Joseph C Cleveland Jr
Job title: Associate Professor, Cardiothoracic Surgery
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
2 years ago
In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
Trials covered in detail include:
00:39: PACMAN AMI: Effects of Alirocumab on Coronary Atherosclerosis Assessed by Serial Multimodality Intracoronary Imaging in Patients…
View more
Author(s):
Flora Kovacs
,
Sumaira Macdonald
Added:
3 years ago
Abstract
Both carotid endarterectomy (CEA) and carotid artery stenting (CAS) are associated with small, but clinically important and discrepant, rates of procedural complications, including cerebral and myocardial ischaemic events, cranial nerve injury and access site haematoma. Embolic protection devices (EPDs) may lower the rate of ipsilateral ischaemic events during CAS and are considered by…
View more
Foreword
Author(s):
David Antoniucci
Added:
3 years ago
Article
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
1 year ago
In this short and engaging episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) share their take on the most anticipated trials of EuroPCR 2022.
Which late-breaking science trials could have the most impact on practice? What are the considerations and challenges? What are the latest advances in interventional cardiology?
…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
5 months ago
What are the top late-breaking trials from #TCT2023?
TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.
Dive into this practical and engaging discussion and learn more about the…
View more
Author(s):
Holger Eggebrecht
,
Axel Schmermund
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) has become a highly effective and beneficial treatment option for patients with severe symptomatic aortic valve stenosis. The randomized Placement of AoRtic TraNscathetER Valves (PARTNER) trials have shown that (1) TAVI using the balloon-expandable Edwards Sapien valve implanted via the transfemoral (TF) or transapical (TA) route is superior with…
View more